These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

453 related articles for article (PubMed ID: 18274559)

  • 1. Treatment strategies for allergy and asthma.
    Holgate ST; Polosa R
    Nat Rev Immunol; 2008 Mar; 8(3):218-30. PubMed ID: 18274559
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunoregulation by targeting T cells in the treatment of allergy and asthma.
    Larché M
    Curr Opin Immunol; 2006 Dec; 18(6):745-50. PubMed ID: 17010586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of allergen immunotherapy in allergic asthma.
    Zhang W; Lin C; Sampath V; Nadeau K
    Immunotherapy; 2018 Jun; 10(7):579-593. PubMed ID: 29569506
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Allergen-specific immunotherapy: from therapeutic vaccines to prophylactic approaches.
    Valenta R; Campana R; Marth K; van Hage M
    J Intern Med; 2012 Aug; 272(2):144-57. PubMed ID: 22640224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Biological engineering for new asthma therapy].
    Van Hage M; Grönlund H; Gafvelin G
    Lakartidningen; 2008 Jun 25-Jul 1; 105(26-27):1942-5. PubMed ID: 18681377
    [No Abstract]   [Full Text] [Related]  

  • 6. Allergen-specific immunotherapy. Present state and directions for the future.
    Malling HJ
    Allergy; 1999; 54 Suppl 50():30-3. PubMed ID: 10466034
    [No Abstract]   [Full Text] [Related]  

  • 7. Recent advances in immunotherapy for allergic diseases.
    El-Qutob D; Mencia G; Fernandez-Caldas E
    Recent Pat Inflamm Allergy Drug Discov; 2014 Jan; 8(1):24-35. PubMed ID: 24237114
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The efficiency of peptide immunotherapy for respiratory allergy.
    Incorvaia C; Montagni M; Ridolo E
    Expert Rev Clin Pharmacol; 2016 Jun; 9(6):831-7. PubMed ID: 26901667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subcutaneous allergen immunotherapy may be a suitable treatment for exacerbator allergic asthma.
    Amat F; Sese L; Hayat M; Bourgoin-Heck M; Just J
    Ann Allergy Asthma Immunol; 2018 Aug; 121(2):258-259. PubMed ID: 29803710
    [No Abstract]   [Full Text] [Related]  

  • 10. Conference scene: recent advancements in immunotherapy.
    Finegold I
    Immunotherapy; 2012 Feb; 4(2):149-50. PubMed ID: 22339458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention and treatment of allergic asthma in pregnancy: from conventional drugs to new therapeutical approaches.
    Cadavid AP; Bannenberg GL; Arck PC; Fitzgerald JS; Markert UR
    Curr Pharm Biotechnol; 2011 May; 12(5):758-64. PubMed ID: 21342121
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Allergy vaccines: dreams and reality.
    Crameri R
    Expert Rev Vaccines; 2007 Dec; 6(6):991-9. PubMed ID: 18377361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel immunotherapeutic approaches for allergy and asthma.
    O'Mahony L; Akdis M; Crameri R; Akdis CA
    Autoimmunity; 2010 Nov; 43(7):493-503. PubMed ID: 20380589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA-based immunotherapeutics for the treatment of allergic disease.
    Horner AA; Van Uden JH; Zubeldia JM; Broide D; Raz E
    Immunol Rev; 2001 Feb; 179():102-18. PubMed ID: 11292014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of SQ house dust mite (HDM) SLIT-tablet treatment of HDM allergic asthma.
    Canonica GW; Virchow JC; Zieglmayer P; Ljørring C; Smith IM; Mosbech H
    Expert Rev Clin Immunol; 2016 Aug; 12(8):805-15. PubMed ID: 27322777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An immunological overview of allergen specific immunotherapy -- subcutaneous and sublingual routes.
    Ozdemir C
    Ther Adv Respir Dis; 2009 Oct; 3(5):253-62. PubMed ID: 19880430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allergen-specific immunotherapy: towards combination vaccines for allergic and infectious diseases.
    Edlmayr J; Niespodziana K; Focke-Tejkl M; Linhart B; Valenta R
    Curr Top Microbiol Immunol; 2011; 352():121-40. PubMed ID: 21626347
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Immunological mechanisms in allergen-specific immunotherapy: impact on future trends in type-1 allergy management].
    Ebner C
    Wien Med Wochenschr; 1999; 149(14-15):438-41. PubMed ID: 10584289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advances and highlights in allergen immunotherapy: On the way to sustained clinical and immunologic tolerance.
    Berings M; Karaaslan C; Altunbulakli C; Gevaert P; Akdis M; Bachert C; Akdis CA
    J Allergy Clin Immunol; 2017 Nov; 140(5):1250-1267. PubMed ID: 28941667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The immunological background of the allergen vaccines application].
    Rogala B
    Wiad Lek; 1999; 52(11-12):539-46. PubMed ID: 10745688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.